Bowhead Specialty Holdings Inc. (NYSE:BOW) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of Bowhead Specialty Holdings Inc. (NYSE:BOW - Get Free Report) have earned a consensus rating of "Moderate Buy" from the six analysts that are presently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $39.67.

BOW has been the topic of several recent analyst reports. JPMorgan Chase & Co. upped their price target on Bowhead Specialty from $30.00 to $35.00 and gave the company a "neutral" rating in a research note on Tuesday, April 8th. Keefe, Bruyette & Woods boosted their price objective on Bowhead Specialty from $43.00 to $45.00 and gave the company an "outperform" rating in a report on Friday, May 9th. JMP Securities boosted their price objective on Bowhead Specialty from $38.00 to $40.00 and gave the company a "market outperform" rating in a report on Friday, April 11th. Morgan Stanley boosted their price objective on Bowhead Specialty from $36.00 to $39.00 and gave the company an "equal weight" rating in a report on Monday, May 19th. Finally, Piper Sandler started coverage on Bowhead Specialty in a report on Wednesday, April 16th. They issued an "overweight" rating and a $44.00 price objective on the stock.

Bowhead Specialty Stock Performance

Shares of NYSE:BOW traded up $0.34 during trading on Friday, reaching $32.95. The stock had a trading volume of 211,937 shares, compared to its average volume of 208,644. The business has a fifty day moving average price of $35.90 and a 200-day moving average price of $36.00. The stock has a market cap of $1.08 billion, a PE ratio of 25.15 and a beta of -0.60. Bowhead Specialty has a 1-year low of $24.80 and a 1-year high of $42.29.

Bowhead Specialty (NYSE:BOW - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.34 earnings per share for the quarter, topping analysts' consensus estimates of $0.33 by $0.01. The company had revenue of $174.85 million for the quarter, compared to analyst estimates of $105.17 million. Bowhead Specialty had a return on equity of 12.52% and a net margin of 9.32%. Sell-side analysts expect that Bowhead Specialty will post 1.36 earnings per share for the current year.

Institutional Trading of Bowhead Specialty

Institutional investors and hedge funds have recently made changes to their positions in the stock. SBI Securities Co. Ltd. purchased a new stake in shares of Bowhead Specialty during the 1st quarter valued at about $44,000. Summit Investment Advisors Inc. raised its holdings in shares of Bowhead Specialty by 66.4% during the 4th quarter. Summit Investment Advisors Inc. now owns 1,218 shares of the company's stock valued at $43,000 after buying an additional 486 shares during the period. Nemes Rush Group LLC purchased a new stake in shares of Bowhead Specialty during the 1st quarter valued at about $61,000. KLP Kapitalforvaltning AS purchased a new stake in shares of Bowhead Specialty during the 4th quarter valued at about $107,000. Finally, GAMMA Investing LLC raised its holdings in shares of Bowhead Specialty by 7,651.2% during the 1st quarter. GAMMA Investing LLC now owns 3,333 shares of the company's stock valued at $135,000 after buying an additional 3,290 shares during the period.

Bowhead Specialty Company Profile

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.